Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 1;96(2):E43-E46.
doi: 10.1002/ajh.26040. Epub 2020 Nov 23.

High dose romiplostim as a rescue therapy for adults with severe bleeding and refractory immune thrombocytopenia

Mathilde Roumier  1   2 , Sébastien Le Burel  1   3 , Sylvain Audia  4 , Adrien Chauchet  5 , Marie Gousseff  6 , Mohammed Hamidou  7 , François Liferman  8 , Guillaume Moulis  9 , Bertrand Lioger  10 , Lionel Galicier  11 , Mickael Ebbo  12 , Jonathan London  13 , Solène Poutrel  14 , Louis Terriou  15 , Virginie Zarrouk  16 , Marc Michel  1 , Bertrand Godeau  1 , Matthieu Mahevas  1
Affiliations
Free article

High dose romiplostim as a rescue therapy for adults with severe bleeding and refractory immune thrombocytopenia

Mathilde Roumier et al. Am J Hematol. .
Free article
No abstract available

PubMed Disclaimer

References

REFERENCES

    1. Melboucy-Belkhir S, Khellaf M, Augier A, et al. Risk factors associated with intracranial hemorrhage in adults with immune thrombocytopenia: a study of 27 cases. Am J Hematol. 2016;91(12):E499-E501. https://doi.org/10.1002/ajh.24529.
    1. Provan D, Arnold DM, Bussel JB, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019;3(22):3780-3817. https://doi.org/10.1182/bloodadvances.2019000812.
    1. Khellaf M, Michel M, Schaeffer A, Bierling P, Godeau B. Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count. Haematologica. 2005;90(6):829-832.
    1. Ghanima W, Cooper N, Rodeghiero F, Godeau B, Bussel JB. Thrombopoietin receptor agonists: ten years later. Haematologica. 2019;104(6):1112-1123. https://doi.org/10.3324/haematol.2018.212845.
    1. Rodeghiero F, Stasi R, Giagounidis A, et al. Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials. Eur J Haematol. 2013;91(5):423-436. https://doi.org/10.1111/ejh.12181.

LinkOut - more resources